PPARGC1A and depressive symptom measurement: The therapeutic effect of long-term PA on depression likely includes the optimization of neurotransmitter level and function, hormone regulation, muscle-derived protein (e.g., peroxisome proliferator-activated receptor C coactivator-1α [Pgc-1α] and IL-6), and neurotrophic factors (Phillips, 2017a).